- Home
- QNCX vs PAVS Comparison
QNCX vs PAVS Comparison
Compare QNCX & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- PAVS
- Stock Information
- Founded
- QNCX 2012
- PAVS 2004
- Country
- QNCX United States
- PAVS United States
- Employees
- QNCX N/A
- PAVS N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- PAVS Medicinal Chemicals and Botanical Products
- Sector
- QNCX Health Care
- PAVS Health Care
- Exchange
- QNCX Nasdaq
- PAVS Nasdaq
- Market Cap
- QNCX 85.9M
- PAVS 49.1M
- IPO Year
- QNCX 2019
- PAVS 2019
- Fundamental
- Price
- QNCX $1.61
- PAVS $0.81
- Analyst Decision
- QNCX Strong Buy
- PAVS
- Analyst Count
- QNCX 6
- PAVS 0
- Target Price
- QNCX $8.00
- PAVS N/A
- AVG Volume (30 Days)
- QNCX 143.6K
- PAVS 453.4K
- Earning Date
- QNCX 11-12-2025
- PAVS 08-04-2025
- Dividend Yield
- QNCX N/A
- PAVS N/A
- EPS Growth
- QNCX N/A
- PAVS N/A
- EPS
- QNCX N/A
- PAVS N/A
- Revenue
- QNCX N/A
- PAVS $71,542.00
- Revenue This Year
- QNCX N/A
- PAVS N/A
- Revenue Next Year
- QNCX N/A
- PAVS N/A
- P/E Ratio
- QNCX N/A
- PAVS N/A
- Revenue Growth
- QNCX N/A
- PAVS N/A
- 52 Week Low
- QNCX $0.69
- PAVS $0.32
- 52 Week High
- QNCX $2.45
- PAVS $1.50
- Technical
- Relative Strength Index (RSI)
- QNCX 49.14
- PAVS 51.67
- Support Level
- QNCX $1.56
- PAVS $0.76
- Resistance Level
- QNCX $1.67
- PAVS $0.90
- Average True Range (ATR)
- QNCX 0.07
- PAVS 0.13
- MACD
- QNCX 0.00
- PAVS 0.01
- Stochastic Oscillator
- QNCX 69.70
- PAVS 34.89
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.